Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions

NCT03353545 · clinicaltrials.gov ↗

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapse/Refractory Multiple Myeloma

Sponsor

Genesis Pharma S.A.